Share |
MOUHAMMED KELTA, M.D.
Hematology Oncology Clinic
P.O.Box: 7108
Damascus, Syria
Phone: +963114442257
Mobile phone: +963992200399
E-mail: mkelta@yahoo.com
                                                                         
MOUHAMMED KELTA, M.D.

Date of Birth     :   July 23,1962
Place of Birth    :  Damascus –Syria
Citizenship        :   Syrian
Marital Status   :  Married, Three children

Summary of Qualifications :

American Board of Hematology                                                            - 1998
American Board of Hematology Recertification                                   - 2005                                                      
American Board of Oncology                                                                - 1997
American Board of Oncology Recertification                                        - 2005
American Board of Internal Medicine                                                    - 1995
American Board of Internal Medicine Recertification                            - 2005
Federation Licensing Examination (FLEX)                                           - 1992
Educational Commission for Foreign Medical Graduates (ECFMG)    - 1991

Training :

Visiting Consultant (June 2004)
Bone Marrow Transplant Unit
Fred Hutshinson Cancer Research Center
Seattle- USA

Fellowship (1994-1997) :
Hematology & Medical Oncology Department
University of Illinois Hospitals
Chicago – USA

Residency ( 1992-1994) :
Internal Medicine Department
University of Health Sciences Hospitals
Chicago Medical School
Chicago – USA

Internship(1991-1992) :
Internal Medicine Department
University of Health Sciences Hospitals
Chicago Medical School
Chicago – USA

Medical School (1980-1986) :
Aleppo University, School of Medicine
Basic Medical Sciences (1980-1982)
Clinical Sciences (1982-1986)
Degree: Medical Doctor, Aleppo, Syria

Professional Experience :
11/1986-5/1987         General Practitioner in private clinic                    Damascus, Syria

5/1987-5/1989           Practicing physician at the military hospitals       Damascus, Syria
                                  and clinics during the national service                       
5/1989-11/1989        General Practitioner in private clinic                     Damascus, Syria

11/1989-1/1990         House physician, Ibn El Naphis Hospital             Damascus, Syria

1/1990-6/1991          Student, Stanley H. Kaplan Educational Center    Chicago, Illinois, USA

7/1991-6/1997           Internal Medicine and Hematology/Oncology     Chicago, Illinois, USA
                                   training
7/1997-9/1998           Attending Hematoloy/Oncology physician,          Norfolk, Nebraska, USA
                                   Norfolk Medical Oncology PC              
10/1998-12/1999       Locum Tenens, Hematology/Oncology ,              Chicago, Illinois, USA
                                  Cancer Care Point and Comphealth                           
2/ 2000-7/ 2001         Hematology/Oncology Consultant                        Doha, Qatar
                                  Hamad General Hospital
8/ 2001- 12/ 2003     Consultant and Head Section                                 Jeddah, Saudi Arabia                         
                                  Hematology/ BMT
                                  King Faisal Specialist Hospital and Research      
                                  Center
1/2004- 5/2009         Director, Bone Marrow Transplant  Program        Jeddah, Saudi Arabia    
                                  King Faisal Specialist Hospital and Research      
                                  Center
10/2006- 9/2007       Acting Chairman, Department of Oncology          Jeddah, Saudi Arabia
                                  King Faisal Specialist Hospital and Research      
                                  Center
10/2007- 5/2009       Deputy Chairman, Department of Oncology          Jeddah, Saudi Arabia
                                  King Faisal Specialist Hospital and Research      
                                  Center
6/2009- 12/ 2010      Head Section, Gynecologic Malignancies              University of Damascus
                                  then Hematologic Malignancies                             Damascus, Syria

1/ 2011- 8/2011       Private practice                                                      Damascus, Syria

9/ 2011- Current        Consultant hematology, Director of Adult BMT program
                                  King Faisal Specialist Hospital and Research
                                  Center                                                                     Jeddah, Saudi Arabia


Professional Membership :
American College of Physicians.
American Society of Oncology.
American Society of Hematology.
American Medical Association.


Licensures :
Ministry of Health Registration, Damascus, Syria (1986- now)
Illinois medical license, USA, (July 1991-now)
Wisconsin medical license, USA, (April 1994-now)
South Dakota medical license, USA (March 1997-December 1998)
Nebraska medical license, USA (February 1997-October 1998)
Indiana medical license, USA (November 1998- November 2000)
State of Qatar License
Kingdom of Saudi Arabia License


Internation / National Speaker :
1.    Lymphoma Profile in Qatari Citizens: A10 year study
      Presented at The International Symposium on New Trends in The    
      Management of Lymphoma, Kuwait, November 2000
2.    CML Update, 4th Pan Arab Congress, Doha, Qatar, March 2002
3.    Pain Management, King Fahed Hospital, Medina, Saudi Arabia, April 2002
4.    Sickle Cell Anemia update, Alnoor Hospita,l Mekkah, Saudi Arabia  May 2002
5.    First Annual Myeloproliferative disorders symposium, Jeddah, Saudi Arabia, October 2002
6.    Multiple Myeloma Transplantation, Hamad General Hospita, Doha, Qatar, January 2003
7.    CML Update, 5th Pan Arab Congress, Damascus Syria, October 2003
8.    Burkitt Lymphoma and Lymphoblatic Lymphoma, Second Annual Hematology Symposium, Jeddah, Saudi Arabia, Sebtember 2003
9.    Writing Scientific Paper, Jeddah, Saudi Arabia, October, 2003
10.    CML Update, The Fifth International Symposium on Hematology and Transfusion Medicine, Riyadh, Saudi Arabia, March 2004
11.    Board Review Course Jeddah, Saudi Arabia, March 2004
12.    Velcade- Update on Multiple Myeloma, Hilton Jeddah, Saudi Arabia, October 2004,
13.    Non Hodgkin Lymphoma Update, First Non Hodgkin Lymphoma Workshop Hilton Jeddah, Saudi Arabia, December 2004
14.    Bone Marrow Transplantation in Multiple Myeloma.The Fifth Oncology  Symposium,  Jordan, April  2006
15.    Neurologic Complications of Hematologic Disorders, Neurology Symposium, KFSHRC, May  2006
        16. Multiple Myeloma Update-2008, Hilton Hotel, Saudi Arabia, February, 2008 


Member Organizing Committee

1.    4th Pan Arab Congress, Doha, Qatar, March 2002
2.    Myeloproliferative Disorders Symposium, Jeddah, October 2002
3.    Second Annual Hematology Symposium September 2003
      4.   Patient Care Day, Adult Hematology/ BMT Support Group Jan. 24, 2006
5.    Institution Review Board (IRB), Hamad General Hospital, Doha, Qatar, 2001
6.    Institution Review Board (IRB), King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia, 2002 - 2005
7.    Infection Control Committee, King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia, 2002-2006
8.    Transfusion Committee, member since July 2006
.

Chairman Organizing Committee

1.    Saudi - BMT 2004 International Conference, April 2004
2.    Blood Transfusion Committee, King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia July 2004- June 2006
3.     Institution Review Board (IRB), King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia 2006- May 2009

4.    Drug Utilization/ Antibiotic Utilization Subcommittee, King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia, 2005- 2006

Appreciation Certificates

Timely Completion of medical records, King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia 2003

Perfect dictation providing complete documentation, King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia 2004

JCIA Accreditation

Participation in initial accreditation and 3 year re-accreditation, King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia

Leading role in writing the internal policies and procedures (IPP’s) for the Hematology/BMT unit, King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia

Researches and Publications :

■Review focusing on low back pain, published in Syria as a M.D. graduation thesis, 1986

■ Several research protocols for outpatient clinical drug trials in sickle cell disease including the protocol, 2-deoxy 5-azacytidine and fetal hemoglobin induction in sickle cell anemia  University of Illinois – USA.

■ Abstract on Anti-Angiogenic Treatment of Metastatic Melanoma, Renal Cell and Bladder Cancer with Thalidomide (F.Fata, M.Kelta, R. Hostetter), Cancer Treatment Centers of America, Goshen, Indiana- USA) proceedings of ASCO, volume 19, 2000, Abstract # 1883A. selected by Qatar Medical Journal, Vol.10/ NO.1/ June 2001

■ Lymphoma Profile in Qartari Citizens: A10 year study, Awidi Abbadi, U. Homsi,
K. Rasul, A. Chong, B. Azadeh, G. Ejekam, A. Haidar, Z. Fawzi, A. Mubarak, A. Al-Hassan, M. Kelta, T. Ismail, M. Abu Laban
Presented in part at the international symposium on new trends in the management of lymphoma, Kuwait, 6-8 November, 2000.
Published in Qatar Medical Journal, Vol.10, Number (1), June 2001 

■ Review Article on Primary Mediastinal B-cell lymphoma; A review of Pathology and Management
Koen van Besien, Mouhammed Kelta, Pranay Bahaguna. From the Section of Hematology and Oncology, University of Illinois at Chicago and Department of Medicine, Cook County Hospital, Chicago-Illinois, USA. Published in Journal of
Clinical Oncology (JCO), March 15, 2001, Volume 19, Number 6

■ Review Article on Breast Cancer and Pregnancy, Kelta M., Abbadi A., Sharara H.,
Hostetter R., Helmi I., Hamad General Hospital, Doha, Qatar and Surgical Oncology Unit (Cancer Treatment Centers of America), Indiana, USA, published in Jordan Medical Journal V.35, Number (1), May 2001: 17-23

■ Double-blind, placebo-controlled cross-over study of oral pilocarpine for the prevention of chemotherapy-induced oral mucositis in adult patients with cancer
A. Awidi, U. Homsi, R.I. Kakil, A. Mubarak, A. Hassan, M. Kelta, P. Martinez, S. Sulaiti, A. Al Qady, A. Jamhoury, M. Daniel, C. Charles, A. Ambrose, A.S. El-Aloosy
Published in Eur J Cancer 2001 Nov; 37 (16): 2010-4

■Chemotherapy practice guidelines (77 pages)
M. Kelta, A. Awidi, U. Homsi, R. Kakil, A. Mubarak, A. Hassan,
Published 2001,  Hamad General Hospital-  Doha , Qatar

■ Normal outcome of pregnancy in chronic myeloid leukemia treated with interferon in first trimester: Report of 3 cases and review of the literature, Mubarak A, Kakil R, Awidi A, Al-Homsi U, Fawzi Z, Kelta M, Al-Hassan A. Published in Am J Hematol 2002 Feb; 69 (2): 115-8

■ Study of HER2/neu status in Qatari women with breast carcinoma
Kakil R, Kelta M, Awidi A, Augustin L, Mubarak A, Al-Homsi U, Al-Hassan A, Al-Alosi A, Bener A. Published in Saudi Med J 2003; Vol.24(8): 447-451

■  Kidney Transplantation From Sickle Cell Trait Donor to Sickle Cell Trait Recipient
Khalil ur Rehman, Abdulla Al-Amoudi, Mouhammed Kelta, Abdulla Awad, Kenneth Bridges, Saeed M G Al-Ghamdi. Publishec in Experimental and Clinical transplantation (2007) 2: 698-700
King Faisal Specialist Hospital and Research Center- Jeddah, Saudi Arabia
Brigham and Women’s Hospital, Boston, MA. USA

■ Acute Myeloid leukemia Post-Allogeneic Peripheral Stem Cell Transplant with
Gastric Chloroma
Jalil Ur Rehman, Mohammad, Shinawi, Muhammad Aslam, Mouhammad Kelta
Annals of Saudi Medicine 31(6) November-December 2011: 658-660






  
SSCTG Copyright © 2024 All Rights Reserved
Powered by SyrianMonster Web Service Provider